Detalles de la búsqueda
1.
Second-line immunosuppressant administration for steroid-refractory immune-related adverse events in patients with lung cancer.
Cancer Immunol Immunother
; 72(11): 3765-3772, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37638979
2.
Drug fever after cancer chemotherapy is most commonly observed on posttreatment days 3 and 4.
Support Care Cancer
; 24(2): 615-619, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26108172
3.
A Phase II Study of S-1 for Previously Untreated Elderly Patients with Advanced Non-Small Cell Lung Cancer.
Chemotherapy
; 61(2): 93-8, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26606381
4.
Secondary EML4-ALK-positive lung adenocarcinoma in a patient previously treated for acute lymphoblastic leukemia in childhood: a case report.
Jpn J Clin Oncol
; 44(6): 593-6, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24688086
5.
Phase I/II study of amrubicin and nedaplatin in patients with untreated, advanced, non-small cell lung cancer.
Chemotherapy
; 60(3): 180-4, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25823897
6.
Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers.
Adv Clin Chem
; 112: 155-204, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36642483
7.
Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study.
Thorac Cancer
; 14(28): 2890-2894, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37675546
8.
Prophylactic treatment of dacomitinib-induced skin toxicities in epidermal growth factor receptor-mutated non-small-cell lung cancer: A multicenter, Phase II trial.
Cancer Med
; 12(14): 15117-15127, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37269194
9.
Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-disease small cell lung cancer: protocol of ACIST study.
Thorac Cancer
; 13(16): 2404-2409, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35808894
10.
Efficacy of S-1 after pemetrexed in patients with non-small cell lung cancer: A retrospective multi-institutional analysis.
Thorac Cancer
; 12(17): 2300-2306, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34255933
11.
Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor.
J Clin Med
; 10(18)2021 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34575334
12.
The role of comprehensive analysis with circulating tumor DNA in advanced non-small cell lung cancer patients considered for osimertinib treatment.
Cancer Med
; 10(12): 3873-3885, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33982444
13.
Prediction of Anti-Cancer Drug-Induced Pneumonia in Lung Cancer Patients: Novel High-Resolution Computed Tomography Fibrosis Scoring.
J Clin Med
; 9(4)2020 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32272762
14.
Phase II study of ramucirumab and docetaxel for previously treated non-small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study.
Thorac Cancer
; 11(2): 389-393, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31851428
15.
Phase II trial of a non-platinum triplet for patients with advanced non-small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA.
Thorac Cancer
; 10(3): 452-458, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30628188
16.
Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancer.
Cancer Chemother Pharmacol
; 84(5): 1059-1064, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31486872
17.
Phase II study of nedaplatin and amrubicin as first-line treatment for advanced squamous cell lung cancer.
Thorac Cancer
; 10(9): 1764-1769, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31309738
18.
Stepwise progression from ground-glass opacity towards invasive adenocarcinoma: long-term follow-up of radiological findings.
Lung Cancer
; 60(2): 298-301, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17928095
19.
Heterogeneity of epidermal growth factor receptor mutations within a mixed adenocarcinoma lung nodule.
Lung Cancer
; 60(1): 136-140, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17889960
20.
Effect of IL-18 on the Expansion and Phenotype of Human Natural Killer Cells: Application to Cancer Immunotherapy.
Int J Biol Sci
; 14(3): 331-340, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29559850